Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPA: Satavaptan for Ascites Recurrence
NCT00501384Phase 2Completed
- Sponsor
- Sanofi
- Start
- Apr 2004
- Primary completion
- May 2005
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 2 trial of satavaptan in ascites, sponsored by Sanofi. Started Apr 2004; status: completed.
02
Drugs
satavaptan
03
Conditions
ascites
Beyond the preview
Go deeper on NCT00501384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00501384.